Navigation

TA158 Influenza (prophylaxis) - amantadine, oseltamivir and zanamivir: guidance: understanding NICE guidance

The summary of the key recommendations of the technology appraisal on Influenza (prophylaxis) - amantadine, oseltamivir and zanamivir . It is written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets or any other suitable publication.

This page was last updated: 01 January 2011

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.